The New Precision Oncology Battleground: Tracking FOLR1, CLDN18.2, and cMET
As Antibody-Drug Conjugates (ADCs) reshape the therapeutic landscape, commercial success depends on...
Beyond the Centers of Excellence: Maximizing ROI and Finding the Missing Rare Disease Patient Cohort
The pursuit of patients with rare diseases is a critical but notoriously challenging endeavor for...
Case Study: Optimizing Patient Identification in Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes (MDS) are a group of bone marrow disorders characterized by ineffective...
Driving Commercial Strategy in ALL: The Critical Role of Lab Data
For pharmaceutical commercial teams, understanding the full patient journey is critical. In the...
%20(1).png)
7 Best Practices for Lab Data Licensing: Maximize Value in Oncology & Genomics
By Jason Bhan, MD, Bill Paquin, Chris Hayes, Sundeep Bhan, Michael Cheyne [Bonus: Link to the free...
Shining a Light on Colorectal Cancer Awareness Month
Shining a Light on Colorectal Cancer Awareness Month March is Colorectal Cancer Awareness Month, a...
Keeping the Focus on Kidney Health: Beyond World Kidney Day and the Nuances of CKD
World Kidney Day, observed yesterday on March 13, served as a powerful reminder of the critical...
Beyond Claims: The True Value of Lab Data in Prostate Cancer Therapy Commercialization
Prostate cancer (PC) remains a significant men's health concern, demanding innovative treatment...
Optimizing CLL Commercial Strategies with Lab Insights
Chronic Lymphocytic Leukemia (CLL) presents a complex treatment landscape. While advancements have...
Supporting HAE Commercial Teams with Prognos Health Lab Data
Hereditary angioedema (HAE) is a rare and debilitating condition affecting an estimated 1 in 50,000...